About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
19 12, 2024

XAU/USD approaches recent lows around $2,580

By |2024-12-19T21:03:01+02:00December 19, 2024|Forex News, News|0 Comments


XAU/USD Current price: $2,590.05

  • The Bank of Japan and the Bank of England kept rates on hold in their December meetings.
  • The United States upwardly revised Q3 Gross Domestic Product figures.
  • XAU/USD resumed its slide and aims for lower lows below $2,580.   

Spot Gold came under selling pressure early in the American session after peaking at $2,626.31 during European trading hours. The US Dollar (USD) shed some ground throughout the first half of the day after reaching extreme overbought conditions in the Federal Reserve’s (Fed) aftermath. The United States (US) central bank delivered a hawkish cut, trimming the benchmark interest rate by 25 basis points (bps), while scaling back policymakers’ perspective on potential cuts in the upcoming years.

Global stock markets felt the heat, as most Asian and European indexes settled in the red on Thursday, following Wall Street’s slump post-Fed. US indexes kick-started the new day, trimming part of their Wednesday’s losses, but remain under strong selling pressure, helping the USD resume its advance.

Also backing the Greenback, US data was upbeat. The country published the final estimate of the Q3 Gross Domestic Product (GDP), which showed that annualized growth was higher than previously estimated, confirmed at 3.1% vs. the previous 2.8%.  Initial Jobless Claims for the week ended December 13 declined to 220K from 242K in the previous week, also beating the expected 230K.

Also worth noting is that the Bank of Japan (BoJ) and the Bank of England (BoE) announced their decisions on monetary policy. The BoJ kept the short-term rate target unchanged in the range of 0.15%-0.25%, and give no clues on what’s next for monetary policy. The Bank of England also kept the benchmark interest rate on hold at 4.75%, albeit MPC members delivered a dovish message, reiterating a gradual approach to rate cuts coming up next.

XAU/USD short-term technical outlook

From a technical point of view, the XAU/USD is at risk of falling below its recent multi-week low at $2,582.93. The daily chart shows the pair trimmed almost all its intraday gains. Gold is currently below its 20 and 100 Simple Moving Averages (SMAs), below the longer one for the first time since October 2023. The 200 SMA, in the meantime, maintains its bullish slope around the $2,470 level. Finally, technical indicators offer neutral-to-bearish slopes well into negative territory, far from suggesting the pair may recover again.

In the near term, and according to the 4-hour chart, XAU/USD seems to have completed its corrective advance and is ready to reach fresh lows. The bright metal is developing below all its moving averages, with the 20 Simple Moving Average heading firmly south below the longer ones, reflecting sellers’ strength. Technical indicators, in the meantime, have retreated from their intraday peaks, anyway, set below their midlines.

 Support levels: 2,582.90 2,568.80 2,554.10

Resistance levels: 2,603.20 2,617.55 2,632.00



Source link

19 12, 2024

USD/JPY Outlook: Fed Signals Fewer 2025 Cuts, BoJ Stays Silent

By |2024-12-19T19:41:07+02:00December 19, 2024|Forex News, News|0 Comments

  • The Fed predicted fewer rate cuts in the coming year.
  • Fed policymakers have assumed a less dovish stance due to the resilient US economy.
  • The Bank of Japan gave little clues on future moves.

The USD/JPY outlook took a sharp bullish turn on Wednesday as the Fed forecasted fewer cuts in 2025, and the BoJ remained mum on the outlook for rate hikes. As a result, the dollar soared while the yen collapsed. 

If you are interested in automated forex trading, check our detailed guide-

The Federal Reserve met on Wednesday and cut interest rates by 25 bps. However, it was a hawkish cut because policymakers predicted fewer rate cuts in the coming year. According to forecasts, the central bank might only cut by 50 bps in 2025. This was a 50-bps drop from September’s forecast. As a result, markets slashed bets for rate cuts, boosting the dollar. 

Although traders had expected a change in the outlook for monetary easing, the Fed’s cautious forecast came as a surprise. Policymakers have assumed a less dovish stance due to the resilient US economy. Moreover, Trump’s administration might come with more economic growth and a spike in inflation, which would require a more restrictive policy. 

On the other hand, the Bank of Japan kept rates unchanged on Thursday and gave little clues on future moves. Market participants had expected some hints about a rate hike. However, Governor Ueda said the central bank needed time to assess incoming data. At the same time, the uncertainty about Trump’s policies has clouded the outlook. The meeting was a disappointment, leading to a collapse in the yen.

USD/JPY key events today

  • Final GDP q/q
  • Unemployment Claims

USD/JPY technical outlook: Bullish spike continues uptrend

USD/JPY 4-hour chart

On the technical side, the USD/JPY price has made an impulsive bullish move that has broken past major resistance levels. The move started after a retest of the 30-SMA as support. Bulls have been in the lead since the price broke above the 30-SMA. Therefore, when it pulled back, bulls were ready to make a new high. As a result, the price broke above the 154.00 and the 156.00 key resistance levels. At the same time, the RSI entered the overbought region, indicating a surge in bullish momentum. 

If you are interested in guaranteed stop-loss forex brokers, check our detailed guide-

Bulls are eyeing the 158.01 resistance and might soon reach it. However, after such a sharp move, bulls might get exhausted at the next resistance, leading to a pullback to retest recently broken key levels.

Looking to trade forex now? Invest at eToro!

67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Source link

19 12, 2024

Less Fat, More Muscle: A Natural Catalyst – T Nation Content

By |2024-12-19T19:39:31+02:00December 19, 2024|Dietary Supplements News, News|0 Comments


The Physique Fine-Tuner

This body composition supplement isn’t made for people who aren’t training and eating right. It’s made for those who want to fine-tune their bodies.

Back in the 1990s, a fitness writer was sued by a supplement company for 10 million dollars. What did he do? He pointed out that a woman was pregnant.

See, back then, makers of fat burners relied on before and after photos to sell their products. One particular magazine ad showed a “before” photo of a pretty girl with a stomach bulge. The “after” photo showed her in a bikini – tanned and fit with no belly fat in sight – ready to compete in a physique competition. According to the ad, the fat burner was responsible for her transformation.

The problem? Well, this fitness writer knew the woman… and he knew that she was pregnant in her “before” photo. He exposed this in an article and was sued. Luckily, he avoided the legal fees by promising never to hurt their feelings again. The nuisance suit was dropped.

Many companies still use scurrilous advertising. They make unrealistic promises and unsubstantiated claims. They often use psychology to prey on desperate overweight people.

But a fat-loss product shouldn’t be marketed to obese people who aren’t even dieting or exercising. Fat-loss supplements, if they’re truly legit, should be marketed toward people who already eat well and exercise and just want to fine-tune their physiques. That’s who Carbolin 19 (Buy at Amazon) was designed for.

Forskolin 1,19 Carbonate – The Anabolic Thermogenic

This plant-derived substance has a body of solid research to back its use in not only burning fat but building muscle too. It’s often regarded as the closest thing science has to “exercise in a pill” for its body-composition-altering effects, even in people who don’t exercise.

It does all this primarily by stimulating the production of an enzyme named adenylate cyclase, which increases levels of a cellular messenger called cyclic AMP, or cAMP for short. Here are the highlights of a few forskolin studies:

  • Female subjects in an 8-week study lost a mean of 9 pounds of weight while experiencing gains in lean body mass (without weight training).
  • The total body weight of a mixed group of men and women in a 12-week study decreased by 3 pounds while experiencing increases in muscle weight (without resistance training).
  • The forskolin users in a mixed-sex group of 50 test subjects experienced a 1.78 percent increase in lean body mass and a decrease in mean body fat from 35.8 to 34.0 percent.
  • Young overweight male forskolin users in a 12-week trial experienced a 17% increase in free testosterone on average, some up to 23%. The average participant also lost 10 pounds of fat mass and increased their lean body mass by 8 pounds

Some of those numbers above aren’t mind-blowingly impressive until you realize that most of these test subjects weren’t lifting weights or changing their diets. Also, in most of these studies, the researchers only supplied their subjects with small doses of plain forskolin: the cheap stuff.

While their results were good, imagine if the studies’ subjects had been weight training and managing their diets. And imagine if they’d all been using the more bioavailable, longer-lasting form (forskolin carbonate).

The Fine-Tuning Agent: Forskolin 1,9-carbonate

Forskolin has been around for years, but most companies producing it don’t bother to isolate and purify the main ingredient. They just collect the dried leaves of the coleus forskohlii plant, grind them up, and put them in capsules. As lame as that approach is, it sometimes works in certain situations, like maybe they luck out and find a crop particularly rich in forskolin. It’s hit or miss.

The right way to manufacture a potent forskolin product is to isolate the active ingredient, then purify it and esterify it (bind it with a carbonate ester). The end product, forskolin 1,9 carbonate, is much more bioavailable, and its efficacy in the body extends from 4 hours to about 12 hours. That’s exactly what Biotest did when producing Carbolin 19 (Buy at Amazon).

It’s not a “magic pill.” You won’t go from overweight to lean and muscular in a month. But you will better release and burn stored body fat, build a little more muscle, and reap the benefits of a modest testosterone boost.

In other words, it’ll make fine-tuning your physique easier and faster. Your “after” photo will look great, even if you weren’t pregnant in your “before” pic.



Source link

19 12, 2024

ADA Bears Push for $0.64 After 14% Price Drop

By |2024-12-19T19:38:13+02:00December 19, 2024|Crypto News, News|0 Comments

Cardano’s ADA is currently down by more than five percent and is trading below the crucial $1 mark. Down by more than 14 percent in the last seven days, ADA chart shows a minor correction but nothing major has changed. 

The main question remains whether the market is already in the fourth wave of a larger correction or if it’s still in an extended third wave. Key support levels will be critical in determining the next price movement.

Key Support Levels to Watch 

The most critical level to monitor is the 64-cent mark. This is the main support level that needs to hold for a bullish scenario to remain intact. If ADA breaks and sustains below 64 cents, it would signal a more bearish outlook. However, for now, ADA remains above this level, which is positive for the bullish case.

If ADA experiences a further decline, there is additional support around 76 cents. This level corresponds with the 38.2% Fibonacci retracement, which is a typical target for a fourth wave correction. As long as ADA holds above these support levels, there is still potential for upward movement.

Smaller Time Frame Correction and Potential for Reversal 

On a smaller time frame, ADA has been moving within a corrective price channel since the high formed in early December. While there have been some rebounds, these have been in a three-wave structure, which doesn’t mean a strong confirmation of a trend reversal yet. This three-wave move suggests that the current rally may not be the start of a larger upward trend, but more of a short-term correction.

The next key support levels on the smaller time frame are 93 cents and 83 cents. If ADA drops below 83 cents, it would confirm that the larger fourth wave correction is unfolding. Below that, further support can be found at 76 cents and 64 cents.

Bullish Potential and Next Targets 

If the price holds above 64 cents and the corrective structure resolves, ADA could still experience an upward move. There is potential for the price to reach $1.42, $1.72, or even $2.36 in the next wave. However, this is contingent on the market holding key support levels and seeing a reversal in price action.

Source link

19 12, 2024

‘Tomarket’ Telegram Game Dumps TON for Aptos Ahead of Token Launch and Airdrop

By |2024-12-19T19:30:15+02:00December 19, 2024|News, NFT News|0 Comments


Tomarket, a popular Telegram game playable on the messaging platform as a mini app, is ditching its original plan to launch its token on The Open Network (TON) and will instead deploy TOMA on rival layer-1 network Aptos.

With 50 million total users and 6 million daily active users, Tomarket will launch its TOMA token on December 20, with an airdrop to players who met certain criteria within the game.

Tomarket has handed out allocations of tokens across multiple airdrop waves, but players have been unable to withdraw or trade the token. The app’s developers previously said that the TOMA token was generated, but clarified afterwards that the term was used to describe token allocations within the app. And now, Tomarket won’t ultimately deploy to TON.

“Aptos’ high speed and reliable infrastructure provides the scalability Tomarket needs to support its growing user base while delivering smooth, efficient blockchain experiences,” a Tomarket core team member who goes by Miles told Decrypt.

Following next week’s token launch, Tomarket plans to expand its offerings, including introducing more games, enhancing its FarmingPool rewards program, and launching an aggregator of decentralized exchanges, or DEXs.

Most Telegram-based crypto games, including heavyweights like Hamster Kombat and Notcoin, have opted to deploy on TON, helping to drive adoption of the chain this year. TON is now the 16th most valuable cryptocurrency by market cap, per data from CoinGecko, rising in price by about 190% over the past year.

Tomarket isn’t the first game to choose an alternative path, however: tap-to-earn combat game MemeFi recently launched its token on Sui, after pivoting from its original chain of Ethereum layer-2 network Linea.

Edited by Andrew Hayward

GG Newsletter

Get the latest web3 gaming news, hear directly from gaming studios and influencers covering the space, and receive power-ups from our partners.



Source link

19 12, 2024

Natural Gas Price Outlook – The Natural Gas Market Continues to See Buyers

By |2024-12-19T19:02:13+02:00December 19, 2024|Forex News, News|0 Comments


Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party’s services, and does not assume responsibility for your use of any such third party’s website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.Risk DisclaimersThis website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.



Source link

19 12, 2024

GBP/USD Analysis Today 19/12: Under Pressure (Chart)

By |2024-12-19T17:39:59+02:00December 19, 2024|Forex News, News|0 Comments

  • We have often mentioned that this trading week would be important and exciting. As expected, the US dollar has risen strongly against other major currencies after the Federal Reserve cut US interest rates by 25 basis points.
  • Moreover, it indicated the end of a series of successive cuts.
  • As a result, the price of the pound sterling against the US dollar GBP/USD fell to the support level of 1.2562, the lowest level for the currency pair in 3 weeks, before settling around the level of 1.2606 at the time of writing the analysis and ahead of the important Bank of England announcement later today.

The US Federal Reserve backs away from future rate cuts

The pound-dollar losses deepened after the Federal Reserve “outperformed the hawks” and backed away from its expected US interest rate cuts for 2025. According to the US central bank’s policy statement, one member of the Federal Open Market Committee (FOMC) – Beth Hammack – voted to leave US interest rates unchanged. New forecasts from the FOMC showed that officials believe fewer rate cuts are likely in 2025 and 2026.

They now expect only 50 basis points worth of cuts, meaning two cuts, while the September projections showed that cuts would be possible in 2025. As a result, the Federal Reserve is now expected to cut US interest rates two more times in 2026 and only once in 2027, raising the final interest rate to 3.1%. In general, the higher base rate for the Federal Funds rate would support US Treasury yields, which affect commercial interest rates, thereby increasing the attractiveness of US debt-based assets. This would attract foreign capital inflows, boosting the value of the US dollar.

Trading Tips:

The sterling dollar price will remain bearish amid cautious anticipation until the Bank of England announces later today. Decisively, be careful until the reaction to the bank’s announcements to determine the closing path for this week.

US Stocks Tumble After Interest Rate Hints

According to stock trading platforms, US stock indices experienced strong selling, with losses exceeding 3%, and US 10-year Treasury yields rose to their highest levels in seven months. Following the reaction to the Fed’s announcement and the statements of its chairman, Jerome Powell, the bank cut interest rates as expected, but dashed hopes for more rate cuts in 2025. As a result, the selling of US stocks was the worst after a meeting since the beginning of the pandemic, and the message was clear: the sustained rise and risk in the past two years are suddenly in danger.

Historically, the last time the S&P 500 index experienced such losses on the day of the Fed’s decision was on September 17, 2001, when the index fell by about 5%. It fell by 12% on March 16, 2020, a day after the central bank’s emergency meeting over the weekend during the pandemic.

Technical Analysis for the GBP/USD pair today:

The overall trend of the GBP/USD pair remains bearish, and if the pound does not receive a strong boost from today’s Bank of England announcement. Technically, the bears may find a stronger opportunity for a stronger downward move, and the support level of 1.2487, which the currency pair recorded at the end of last month’s trading, may be an easy target, as it is the lowest level for the currency pair since May 2024. Conversely, and on the same time frame, the initial downward trend will not be broken without the currency pair moving above the resistance of 1.0800 again. Finally, we still expect to sell the GBP/USD from every upward level. In addition to the Bank of England’s announcement, the GBP/USD will be affected today by the announcement of the US GDP growth reading and the number of weekly jobless claims. This, in addition to the extent of investors’ risk appetite.

Ready to trade our daily GBP/USD Forex analysis? We’ve made this UK forex brokers list for you to check out. 

Source link

19 12, 2024

Nationwide Recall of Supplement Containing Drugs That Can Kill

By |2024-12-19T17:38:21+02:00December 19, 2024|Dietary Supplements News, News|0 Comments


A nationwide recall of supplements sold for blood sugar support has been announced due to the presence of dangerous drugs prescribed for diabetes.

The recall of Fouzee SugarLin Herbal Formula capsules was called voluntarily by California-based Shoppers-Plaza on Monday and announced by the U.S. Food and Drug Administration (FDA) on Wednesday.

The products were sold as herbal supplements intended to support blood sugar balance, but they contain prescription-grade diabetes drugs metformin and glyburide, which both can come with fatal side effects if used incorrectly.

The FDA described the products as “an unapproved new drug for which safety and efficacy have not been established and, therefore, subject to recall.”

Newsweek has reached out to Shoppers-Plaza for comment via email.

Metformin and glyburide are both active ingredients in several FDA-approved prescription drugs used to treat type 2 diabetes and should only be available with prescriptions.

Both of these drugs could cause dangerous drops in blood sugar levels, called hypoglycemia, characterized by weakness, dizziness, sweating, paleness, increased heart rate and confusion.

If left untreated, hypoglycemia can quickly lead to loss of consciousness, seizures, coma or death.

Metformin comes with an added possible side effect called lactic acidosis. The condition is rare but can be fatal, involving the build-up of lactic acid in the blood.

Symptoms of lactic acidosis include nausea, vomiting, fatigue, body aches, respiratory distress, abdominal pain and fast, deep breathing.

Consumers who have taken these products and are experiencing any symptoms that might be linked with the drugs should contact their healthcare provider.

The FDA has instructed anyone who purchased Fouzee SugarLin Herbal Formula to stop taking it immediately and return the product to its place of purchase for a full refund.

Herbal supplement
A woman putting herbal medicine tablets into her hand to take them. The SugarLin supplements were sold as herbal dietary supplements but contain two prescription drugs that come with dangerous side effects.

Doucefleur/iStock / Getty Images Plus

The product was promoted and sold online nationwide on various websites, including www.shoppers-plaza.com, and possibly in some retail stores.

It is packaged in a white bottle containing 180 capsules with the product code “26656690477.”

The packaging describes the product as a herbal dietary supplement that promotes healthy energy levels, supports healthy bodily functions and promotes healthy weight management.

Shoppers-Plaza is notifying its distributors and customers by email and on its website and social media channels to arrange for the return of all the recalled products.

Consumers with questions are advised to contact Anthony Robinson of BICO Legal and Compliance Consulting, LLC, by calling 786/796-6708 or emailing info@bicolegalcompliance.com from Monday to Friday, 9:00 a.m. to 5:00 p.m. ET.

Any health problems connected to this recall can be reported to the FDA by completing its online form.

Other ongoing supplement recalls include joint pain supplements that contain anti-inflammatory drugs, supplements sold as tejocote root that actually contain poison and hyaluronic acid tablets that contain prescription drugs.

Do you have a tip on a food story that Newsweek should be covering? Is there a nutrition concern that’s worrying you? Let us know via science@newsweek.com. We can ask experts for advice, and your story could be featured in Newsweek.



Source link

19 12, 2024

$782 Million Liquidation Tsunami Punishes XRP Bulls: Bottom Hit?

By |2024-12-19T17:36:58+02:00December 19, 2024|Crypto News, News|0 Comments

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Over the past 24 hours, the cryptocurrency market was hit by a tsunami of liquidations, which took away almost $800 million in traders’ positions. Diving deeper into the data from CoinGlass, it is apparent that most of them, namely, almost 84% of them, came from long positions. In addition, one of the highlights of the past large-scale destruction of traders is the situation with trading on derivatives on XRP, the third largest cryptocurrency right now.

Over the past 24 hours, $30.75 million worth of long positions and $10.94 million worth of short positions were liquidated in the trading of perpetual futures on XRP. At the same time, a surge in liquidations by bearish-minded traders occurred only in the last hour, and before that, the imbalance in liquidations reached more than 1,000%. 

Related

Ripple CTO Explains Why XRP Still Matters

As a result, right now, XRP is at the top of the market in terms of liquidations, which on the one hand demonstrates increased interest in the cryptocurrency as a trading instrument, and on the other hand displays its price trends. 

Article image
XRP to USD by CoinMarketCap

For the period under review, the price of XRP collapsed by more than 16%, reaching a local bottom at $2.17. However, it further managed to regain part of the fall during today’s trading session, recovering by more than 11%. 

Related

XRP Price Chart 'Stays Hilarious,' Says Expert Trader — What Does It Mean?

Right now, the XRP price chart and the overall situation around it literally look like a popular meme and make you wonder: is it over? It remains an open question, but one thing is certain – the market will continue to dump traders ineptly managing risk.

Source link

19 12, 2024

Facts About Self Breast Exams

By |2024-12-19T17:33:42+02:00December 19, 2024|Fitness News, News|0 Comments

“Breast self-exams are no longer recommended.”

When I saw that headline earlier this year, I thought it was a typo. As someone who found my own breast cancer lump that turned out to be stage 3 cancer, I was surprised to learn that many health organizations like the American Cancer Society and National Cancer Institute don’t recommend breast self-exams. And they haven’t for years.

So what happened?

The breast self-exam was created in the 1950s as a convenient and low-cost way for people to catch breast cancer early, when it’s most treatable. But in the 2000s, research found that doing formal breast self-exams (raising your arms, lying down, circular motions, etc.) may not reduce your risk of dying from breast cancer. One meta-analysis comparing women who did routine breast self-exams to those who did not do self-exams found that there was no difference in their breast cancer survival rates. But people who performed self-exams had more false positives and nearly twice as many breast biopsies with no cancer.

Read: What You Need to Know About a Breast Biopsy >>

Without data to show that breast self-exams can decrease the risk of dying from breast cancer — and the possibility of harm from unnecessary testing — breast self-exams are no longer recommended for people of average risk by most professional organizations and healthcare providers. (Average risk means you have no personal or family history or genetic mutation, like BRCA 1 or BRCA 2)

Larry Norton, M.D., a breast medical oncologist at Sloan Kettering Cancer Center, said the guideline shift away from formal breast self-exams doesn’t mean you should stop paying attention to your breasts. It’s called breast self-awareness.

What is breast self-awareness?

Breast self-awareness is being familiar with how your breasts look and feel so you can identify any changes. “The lack of awareness of what’s healthy in your body can inhibit you from identifying something that’s not quite right,” Norton said. “It’s very good to know there’s something different in your body, and it’s very good when you find something different — no matter what that is — to call attention to it.”

Unlike breast self-exams, there’s no timeline or technique to breast self-awareness — it’s basically using your eyes and hands to know what’s normal for you. Signs of breast cancer to look for can include:

  • Lumps
  • Pain
  • Dimples in the skin
  • Discharge or bleeding from the nipple
  • Redness or warmth
  • Swelling/changes in size

Norton said changes in appearance and nipple discharge are more obvious, but knowing how your breasts feel is important because you may be able to pick up on signs of breast cancer that your provider or imaging didn’t catch. “When you touch your breast, and you feel an unusual hard place or an unusual place that hurts but didn’t hurt before — those are the things that are a little bit more subtle,” Norton said.

Breast self-exam timing and risks

Although most healthcare providers recommend breast self-awareness over formal breast self-exams, some people may still want to stick with the standard technique and routine. If you do breast self-exams, it’s best to do them three to five days after your period ends, when your breasts are less sensitive or lumpy. If you’re postmenopausal, do the self-exam at the same time each month.

Read: How to Do a Breast Self-Exam >>

The risks associated with formal breast self-exams include false positives and unnecessary biopsies of tissue that’s non-cancerous. Researchers say the mental and financial stress of imaging and biopsies is also part of the reasoning against formal breast self-exams. However, it’s important to note that false-positive results are common, and the chances of getting a false-positive result increase as you age. Concern about false positives shouldn’t stop you from paying attention to your breast health and contacting your healthcare provider if you see or feel anything unusual to you.

Norton said being familiar with your breasts in order to notice changes is the takeaway for self-exams. But neither breast self-awareness nor self-exams are a replacement for mammograms when it comes to screening for breast cancer.

Read: A Mammogram Saved My Life >>

When to get a mammogram

Right now, mammograms are the gold standard for breast cancer screening. According to the latest guidelines from the U.S. Preventive Services Task Force (USPSTF), people who are at average risk should start getting mammograms at age 40 — not 50 as previously recommended. The change reflects the recent data showing that 1 out of 6 new breast cancers develop in people in their 40s, and it aligns with other organizations that offer screening guidelines.

The recommendations for how often to get screened vary from organization to organization, with some saying every year to others saying every one to two years. You should talk to your healthcare provider about what makes sense for your circumstances.

Regardless of guidelines, Norton said if you feel or see something suspicious, contact your healthcare provider right away. “I like to say your body is entrusted to you, and you should do the things that are necessary to honor that trust — and one of them is screening tests and another is just knowing your body. So when something is abnormal, you don’t ignore it.”

This educational resource was created with support from Daiichi Sankyo and Merck.

From Your Site Articles

Related Articles Around the Web



Source link

Go to Top